RARE 股东权益历史(2016–2025)
Ultragenyx Pharmaceutical Inc. (RARE) 各财年年末股东权益(来自 SEC 财报)。
-$80.0MFY2025 · FY2016 以来:$474.0M → -$80.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$80.0M | -131.4% |
| FY2024 | $255.0M | -7.3% |
| FY2023 | $275.0M | -21.9% |
| FY2022 | $352.0M | -61.8% |
| FY2021 | $922.6M | -20.1% |
| FY2020 | $1.2B | +76.6% |
| FY2019 | $653.8M | +7.4% |
| FY2018 | $608.9M | +58.8% |
| FY2017 | $383.5M | -19.1% |
| FY2016 | $474.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议